Company Search:
Advanced Search
Sponsored Links
Cipla Ltd Company Snapshot
Cipla Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cipla Ltd with three other companies in this sector in India: Dr.Reddy's Laboratories Ltd (2017 sales of 140.81 billion Indian Rupees [US$2.15 billion] of which 82% was Global Generics), Lupin Ltd (174.94 billion Indian Rupees [US$2.67 billion] of which 100% was Pharmaceuticals), and Aurobindo Pharma Ltd (149.10 billion Indian Rupees [US$2.28 billion] of which 100% was Pharmaceuticals).

Sales Analysis. Cipla Ltd reported sales of 143.94 billion Indian Rupees (US$2.20 billion) for the fiscal year ending March of 2017. This represents an increase of 5.2% versus 2016, when the company's sales were 136.78 billion Indian Rupees. Sales at Cipla Ltd have increased during each of the previous five years (and since 2012, sales have increased a total of 107%). Sales of New Ventures saw an increase that was more than double the company's growth rate: sales were up 89.1% in 2017, from 503.80 million Indian Rupees to 952.90 million Indian Rupees.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Cipla Ltd
  Stock Performance Chart for Cipla Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/13/2018): 555.50
(Figures in Indian Rupees)
1 Week -0.6%   13 Weeks -0.7%  
4 Weeks -9.2%   52 Weeks -3.8%  
Cipla Ltd Key Data:
  Ticker: CIPLA Country: India
  Exchanges: BOM Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 143,942,900,000
(Year Ending Jan 2018).
Employees: 23,043
  Currency: Indian Rupees Market Cap: 447,704,161,218
  Fiscal Yr Ends: March Shares Outstanding: 805,948,085
  Share Type: Ordinary Closely Held Shares: 322,655,531
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.